Rapid in vitro activity of telavancin against Bacillus anthracis and in vivo protection against inhalation anthrax infection in the rabbit model
W. S. Lawrence, J. E. Peel, R. Slayden, J. W. Peterson, W. B. Baze, M. E. Hensel, E. B. Whorton, D. W. Beasley, J. E. Cummings, I. Macias-Perez
This study evaluates telavancin's in vitro activity against B. anthracis and its protective efficacy in a rabbit inhalation anthrax model, showing 100% survival and effective bacterial clearance.
bioRxiv · Feb 13, 2023 · PreprintMicrobiology